Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.
Clin Cancer Res
; 29(18): 3603-3611, 2023 09 15.
Article
in En
| MEDLINE
| ID: mdl-37227187
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Immunoconjugates
/
Lung Neoplasms
Limits:
Humans
/
Male
Language:
En
Journal:
Clin Cancer Res
Journal subject:
NEOPLASIAS
Year:
2023
Document type:
Article
Country of publication:
Estados Unidos